These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 18172393)

  • 21. Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.
    Chen JH; Wong KH; Chan K; Lam HY; Lee SS; Li P; Lee MP; Tsang DN; Zheng BJ; Yuen KY; Yam WC
    J Clin Virol; 2007 Jun; 39(2):125-31. PubMed ID: 17449318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan.
    Chang SY; Chen MY; Lee CN; Sun HY; Ko W; Chang SF; Chang KL; Hsieh SM; Sheng WH; Liu WC; Wu CH; Kao CL; Hung CC; Chang SC
    J Antimicrob Chemother; 2008 Mar; 61(3):689-93. PubMed ID: 18227088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection of drug-resistant HIV-1 during the early phase of viral decay is uncommon in treatment-naïve patients initiated on a three- or four-drug antiretroviral regimen including lamivudine.
    Bergroth T; Ekici H; Gisslén M; Loes SK; Goh LE; Freedman A; Lampe F; Johnson MA; Sönnerborg A
    J Med Virol; 2009 Jan; 81(1):1-8. PubMed ID: 19031460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and risk factors for developing K65R mutations among HIV-1 infected patients who fail an initial regimen of fixed-dose combination of stavudine, lamivudine, and nevirapine.
    Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Saekang N; Pairoj W; Chantratita W
    J Clin Virol; 2008 Apr; 41(4):310-3. PubMed ID: 18316243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant form 07_BC strains from injection drug users in Taiwan.
    Lin YT; Lan YC; Chen YJ; Huang YH; Lee CM; Liu TT; Wong WW; Yang JY; Wang CT; Chen YM
    J Infect Dis; 2007 May; 195(9):1283-93. PubMed ID: 17396997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-resistant mutation patterns in CRF01_AE cases that failed d4T+3TC+nevirapine fixed-dosed, combination treatment: Follow-up study from the Lampang cohort.
    Saeng-aroon S; Tsuchiya N; Auwanit W; Ayuthaya PI; Pathipvanich P; Sawanpanyalert P; Rojanawiwat A; Kannagi M; Ariyoshi K; Sugiura W
    Antiviral Res; 2010 Jul; 87(1):22-9. PubMed ID: 20382184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of subtype B, multiple circulating recombinant forms and unique recombinants of HIV type 1 in an MSM cohort in China.
    Wang W; Jiang S; Li S; Yang K; Ma L; Zhang F; Zhang X; Shao Y
    AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1245-54. PubMed ID: 18834324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary drug resistance and transmission analysis of HIV-1 in acute and recent drug-naïve seroconverters in Singapore.
    Lee CC; Sun YJ; Barkham T; Leo YS
    HIV Med; 2009 Jul; 10(6):370-7. PubMed ID: 19490177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
    Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW
    Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The emergence of HIV-1 primary drug resistance genotypes among treatment-naïve men who have sex with men in high-prevalence areas in China.
    Yang J; Xing H; Niu J; Liao L; Ruan Y; He X; Feng Y; Li Z; Shao Y
    Arch Virol; 2013 Apr; 158(4):839-44. PubMed ID: 23224760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Primers of gag gene for HIV-1 subtyping in China and application thereof in practice].
    Xin RL; Feng Y; Cheng CL; Hu YY; Meng ZF; Xing H; Shao YM; He X
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):876-80. PubMed ID: 19671285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of nine resistance interpretation systems for HIV-1 genotyping.
    Stürmer M; Doerr HW; Staszewski S; Preiser W
    Antivir Ther; 2003 Jun; 8(3):239-44. PubMed ID: 12924541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular characteristics of HIV-1 CRF01 _ AE strains in Zhejiang province].
    Yao YP; Xin RL; He X; Meng ZF; Pan XH; Guo ZH; Yang JZ; Xu Y; Xing H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Feb; 29(2):161-5. PubMed ID: 18686858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Subtype and sequence analysis of gag and env genes among HIV-1 strains circulating in Beijing residents during 2006].
    Ye JR; Xing H; Liu HL; Hei FX; Zhao YJ; Liu SY; Sun WD; Zhang QY; Zhang Q; Lu HY; He X; Shao YM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Jun; 28(6):586-8. PubMed ID: 17939390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Identification of signature amino acids in the env V3-V4 and flanking regions of human immunodeficiency virus type 1 predominant strains in China].
    Liang H; Xing H; Li JZ; Wei M; Hong KX; Feng Y; Zhao QB; Chen JP; Quan Y; Teng T; Shao YM
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):897-902. PubMed ID: 16029528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors of HIV infection and prevalence of co-infections among men who have sex with men in Beijing, China.
    Zhang X; Wang C; Hengwei W; Li X; Li D; Ruan Y; Zhang X; Shao Y
    AIDS; 2007 Dec; 21 Suppl 8():S53-7. PubMed ID: 18172392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
    Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N
    Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The biological characteristics of predominant strains of HIV-1 genotype: modeling of HIV-1 infection among men who have sex with men.
    Dai D; Shang H; Han XX; Zhao B; Liu J; Ding HB; Xu JJ; Chu ZX
    J Med Virol; 2015 Apr; 87(4):557-68. PubMed ID: 25655808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical utility of genotyping resistance test on determining the mutation patterns in HIV-1 CRF01_AE and subtype B patients receiving antiretroviral therapy in Hong Kong.
    Yam WC; Chen JH; Wong KH; Chan K; Cheng VC; Lam HY; Lee SS; Zheng BJ; Yuen KY
    J Clin Virol; 2006 Apr; 35(4):454-7. PubMed ID: 16386461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.